In this bonus clip from Johnson & Johnson’s weekly live series, The Road to a Vaccine, we touch on the topic of why you should trust science now more than ever. Watch as health experts explain how focusing on science is crucial to ending the COVID-19 pandemic—and why the stakes in the U.S.
The experimental vaccine being developed by pharmaceutical giant Johnson & Johnson is the fourth vaccine to enter the large, Phase 3 trials in the United States that will determine whether they are effective and safe. Paul Stoffels, chief scientific officer of J&J, predicted that there may be enough data to have results by the end … Continued
Nine drugmakers said Tuesday their chief executives signed a pledge promising not to file for regulatory approval or authorization of their experimental Covid-19 vaccines until the shots have been shown to work safely through late-stage clinical testing. The pledge was signed by the heads of AstraZeneca PLC, GlaxoSmithKline PLC, Johnson & Johnson, Merck & Co., … Continued
Johnson & Johnson said on Thursday its experimental coronavirus vaccine prevented hamsters from getting severely ill, as the drugmaker seeks to begin large, late-stage studies in humans later this month. In the pre-clinical study, vaccinated animals lost less weight and had less virus in their lungs and other organs than unvaccinated animals.
Johnson & Johnson said on Thursday it is aiming to begin in September a late-stage study of its experimental vaccine for the novel coronavirus, as researchers work at break-neck speed to develop a shot to combat the fast-spreading pathogen. The New Brunswick, New Jersey-based healthcare conglomerate, which expects to start human trials of its vaccine … Continued
Johnson & Johnson announced Wednesday its early-stage human trial for a potential coronavirus vaccine will begin in the second half of July, earlier than its initial forecast of September. “Based on the strength of the preclinical data we have seen so far and interactions with the regulatory authorities, we have been able to further accelerate the … Continued
Johnson & Johnson said on Thursday it had struck a deal with Emergent BioSolutions Inc to use its manufacturing facilities to help in an effort to make more than 1 billion doses of a vaccine it is testing to stop the novel coronavirus. The U.S. healthcare conglomerate said the deal was the first in a … Continued
In an bid to help speed up the development of potential treatment options and a vaccine for COVID-19, the National Institutes of Health on April 17 announced a new public-private research partnership. Among the 16 companies participating in the effort are Pfizer, Johnson & Johnson and Merck.
The National Institutes of Health and the Foundation for the NIH (FNIH) are bringing together more than a dozen leading biopharmaceutical companies, the Health and Human Services Office of the Assistant Secretary for Preparedness and Response, the Centers for Disease Control and Prevention, the U.S. Food and Drug Administration and the European Medicines Agency to develop … Continued
Hosted by prominent journalist Lisa Ling, Johnson & Johnson’s social-first show titled The Road to a Vaccine series features interviews with scientists, global health leaders and other experts on the COVID-19 front lines to reveal the latest medical advances and collaborations to create a coronavirus vaccine—and hopefully a return to a world without the pandemic.